GNVR · Genvor Inc · Insider Trading
Substantial doubt about the company's ability to continue as a going concern.
“These matters, among others, raise substantial doubt about the Company's ability to continue as a going concern. Management's plans do not alleviate the substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-04-15 | Pawlak Chad Lee Sr. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Compensation award for Mr. Pawlak's conversion of $125,000 in outstanding payables owed by the Company, pursuant to restructured compensation package approved by the Company's Board of Directors as of December 20, 2024. |
Common Stock
|
250,000 |
| 2026-04-07 | Pawlak Chad Lee Sr. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Compensation award for January-March of 2026, pursuant to restructured compensation package approved by the Company's Board of Directors as of December 20, 2024. |
Common Stock
|
250,000 |
| 2026-01-09 | Pawlak Chad Lee Sr. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Compensation award for October-December of 2025, pursuant to restructured compensation package approved by the Company's Board of Directors as of December 20, 2024. |
Common Stock
|
250,000 |
| 2025-12-02 | Jaynes Jessee M |
Director, Chief Research Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Conversion of $186,000 in accrued payables due to Dr. Jaynes at $1.50/share. |
Common Stock
|
124,000 |
| 2025-10-08 | Pawlak Chad Lee Sr. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Compensation award for July-September of 2025, pursuant to restructured compensation package approved by the Company's Board of Directors as of December 20, 2024. |
Common Stock
|
250,000 |
| 2025-07-01 | Pawlak Chad Lee Sr. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Compensation award for April-June of 2025, pursuant to restructured compensation package approved by the Company's Board of Directors as of December 20, 2024. |
Common Stock
|
250,000 |
| 2025-05-08 | Yates Clayton Clopton |
Director, 10% Owner |
Award↑
Filing footnotes — Common Stock (Indirect)
Conversion of $100,000 in accrued payables due to Dr. Yates at $0.25/share. The issuance of the 400K shares to Clayton in consideration of his conversion of $100K in accrued payables, pursuant to Dr. Yates's restructured compensation package, which permits Dr. Yates to convert amounts due to him into common stock. Dr. Yates is a manager of, and may therefore be deemed to be the beneficial owner of shares held in the name of, ACT Holdings, LLC. |
Common Stock
(I)
|
400,000 |
| 2025-05-08 | Jaynes Jessee M |
Director, Chief Research Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Conversion of $100,000 in accrued payables due to Dr. Jaynes at $0.25/share. |
Common Stock
|
400,000 |
| 2025-05-02 | Pawlak Chad Lee Sr. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Conversion into common stock of $125,000 in accrued payables due to Mr. Pawlak at $0.25/share, pursuant to Mr. Pawlak's restructured compensation package, which permits Mr. Pawlak to convert amounts due to him into common stock. |
Common Stock
|
500,000 |
| 2025-04-25 | Pawlak Chad Lee Sr. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Acceleration of monthly compensation awards pursuant to restructured compensation package approved by the Company's Board of Directors as of December 20, 2024. |
Common Stock
|
4,875,000 |
| 2025-04-25 | Pawlak Chad Lee Sr. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Compensation award for January-March of 2025, pursuant to restructured compensation package approved by the Company's Board of Directors as of December 20, 2024. |
Common Stock
|
250,000 |
| 2024-04-17 | Pawlak Chad Lee Sr. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Monthly compensation award pursuant to Mr. Pawlak's employment agreement with Genvor Incorporated dated January 17, 2024. |
Common Stock
|
25,000 |
| 2024-03-16 | Pawlak Chad Lee Sr. |
Director, Chief Executive Officer, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Monthly compensation award pursuant to Mr. Pawlak's employment agreement with Genvor Incorporated dated January 17, 2024. |
Common Stock
|
25,000 |
| 2024-03-15 | MILLER JUDITH SELENE |
Director, Chief Business Officer |
Award↑
Filing footnotes — Common Stock (Indirect)
Monthly compensation award pursuant to Ms. Miller's employment agreement with Genvor Incorporated dated January 16, 2024. |
Common Stock
(I)
|
25,000 |
| 2024-02-16 | MILLER JUDITH SELENE |
Director, Chief Business Officer |
Award↑
Filing footnotes — Common Stock (Indirect)
Monthly compensation award pursuant to Ms. Miller's employment agreement with Genvor Incorporated dated January 16, 2024. |
Common Stock
(I)
|
25,000 |
| 2024-02-13 | MILLER JUDITH SELENE |
Director, Chief Business Officer |
Gift↓
Filing footnotes — Common Stock (Indirect)
On February 13, 2024, Ms. Miller's entity, Good Works Funding Inc., gifted for no consideration 100,000 and 10,000 shares of common stock of Genvor Incorporated to friends of Ms. Miller. |
Common Stock
(I)
|
100,000 |
| 2024-02-13 | MILLER JUDITH SELENE |
Director, Chief Business Officer |
Gift↓
Filing footnotes — Common Stock (Indirect)
On February 13, 2024, Ms. Miller's entity, Good Works Funding Inc., gifted for no consideration 100,000 and 10,000 shares of common stock of Genvor Incorporated to friends of Ms. Miller. |
Common Stock
(I)
|
10,000 |
| 2024-01-16 | MILLER JUDITH SELENE |
Director, Chief Business Officer |
Award↑
Filing footnotes — Common Stock (Indirect)
Monthly compensation award pursuant to Ms. Miller's employment agreement with Genvor Incorporated dated January 16, 2024. |
Common Stock
(I)
|
25,000 |